Clinical Trials Related to Merck Sharp & Dohme LLC

Related studies linked through entity extraction aliases.

Study of Pembrolizumab (MK-3475) Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal/ Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)

Status: COMPLETED
Phase: PHASE3

Ipragliflozin Add-on Long-term Study in Japanese Participants With Type 2 Diabetes Mellitus on Sitagliptin (MK-0431J-849)

Status: COMPLETED
Phase: PHASE3

Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)

Status: COMPLETED
Phase: PHASE3

[18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001)

Status: COMPLETED
Phase: PHASE1

Use-Results Surveillance Study of Sovaldi® Plus Rebetol® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection

Status: COMPLETED
Phase: N/A

Riociguat in Children With Pulmonary Arterial Hypertension (PAH)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Pembrolizumab in Muscle Invasive/Metastatic Bladder Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

Study of Pembrolizumab (MK-3475) in Previously-Treated Participants With Advanced Carcinoma of the Esophagus or Esophagogastric Junction (MK-3475-180/KEYNOTE-180)

Status: COMPLETED
Phase: PHASE2

HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3

Status: COMPLETED
Phase: NA

Study of Single Agent Pembrolizumab (MK-3475) Versus Single Agent Chemotherapy for Metastatic Triple Negative Breast Cancer (MK-3475-119/KEYNOTE-119)

Status: COMPLETED
Phase: PHASE3

Effect of Deep Neuromuscular Block on Surgical Conditions in Morbidly Obese Patients

Status: COMPLETED
Phase: PHASE4

Study of MK-1248 With and Without Pembrolizumab (MK-3475) for Participants With Advanced Solid Tumors (MK-1248-001)

Status: TERMINATED
Phase: PHASE1

HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts

Status: COMPLETED
Phase: NA

Pembro/Carbo/Taxol in Endometrial Cancer

Status: COMPLETED
Phase: PHASE2

Bioavailability of Doravirine (MK-1439) Experimental Nano Formulations in Healthy Adults (MK-1439-046)

Status: COMPLETED
Phase: PHASE1

A Study to Evaluate the Effects of Single Doses of MK-1064 and MK-6096 on Polysomnography (PSG) (MK-1064-003)

Status: COMPLETED
Phase: PHASE1

A Single Dose Study of the Safety, Pharmacokinetics and Pharmacodynamics of MK-1064 (MK-1064-001)

Status: COMPLETED
Phase: PHASE1

Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus

Status: COMPLETED
Phase: PHASE4

Safety, Tolerability, and Immunogenicity of Two Formulations of V114 in Healthy Adults 50 Years of Age or Older (V114-006)

Status: COMPLETED
Phase: PHASE2

Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine

Status: COMPLETED
Phase: EARLY_PHASE1